EMA-EUnetHTA Parallel Consultation

Parallel consultation between EUnetHTA and the European Medicines Agency As of July 2017, EUnetHTA and the European Medicines Agency (EMA) offer parallel consultations on evidence generation plans. This aims to allow medicine developers to obtain feedback from regulators and health technology assessment (HTA) bodies on their development plans to support decision-making on marketing authorisation, health […]